Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

被引：1
|
作者：
Kow, Chia Siang [1 ]
Hasan, Syed Shahzad [2 ,3 ]
机构：
[1] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia
[2] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England
[3] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2021年 / 19卷 / 01期
关键词：
ANTIHYPERTENSIVE DRUGS; OUTCOME INCIDENCE; RISK; ANGIOEDEMA;
D O I：
10.1080/14779072.2021.1842050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [31] Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: Evidence for and against the combination in the treatment of hypertension and proteinuria
    Niels Holmark Andersen
    Carl Erik Mogensen
    Current Hypertension Reports, 2002, 4 : 394 - 402
  • [32] Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: Evidence for and against the combination in the treatment of hypertension and proteinuria
    Andersen, NH
    Mogensen, CE
    CURRENT HYPERTENSION REPORTS, 2002, 4 (05) : 394 - 402
  • [33] Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
    Jiuyang Xu
    Chaolin Huang
    Guohui Fan
    Zhibo Liu
    Lianhan Shang
    Fei Zhou
    Yeming Wang
    Jiapei Yu
    Luning Yang
    Ke Xie
    Zhisheng Huang
    Lixue Huang
    Xiaoying Gu
    Hui Li
    Yi Zhang
    Yimin Wang
    Frederick G. Hayden
    Peter W. Horby
    Bin Cao
    Chen Wang
    Frontiers of Medicine, 2020, 14 : 601 - 612
  • [34] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
    Mustafic, Hazrije
    Fayssoil, Abdallah
    Josseran, Loic
    Ouadahi, Mounir
    Grimaldi-Bensouda, Lamiae
    Dubourg, Olivier
    Annane, Djillali
    Mansencal, Nicolas
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 147 : 58 - 60
  • [35] Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease
    Jennings, Garry L. R.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 212 (11) : 502 - +
  • [36] Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
    Xu, Jiuyang
    Huang, Chaolin
    Fan, Guohui
    Liu, Zhibo
    Shang, Lianhan
    Zhou, Fei
    Wang, Yeming
    Yu, Jiapei
    Yang, Luning
    Xie, Ke
    Huang, Zhisheng
    Huang, Lixue
    Gu, Xiaoying
    Li, Hui
    Zhang, Yi
    Wang, Yimin
    Hayden, Frederick G.
    Horby, Peter W.
    Cao, Bin
    Wang, Chen
    FRONTIERS OF MEDICINE, 2020, 14 (05) : 601 - 612
  • [37] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
    Mustafic, Hazrije
    Fayssoil, Abdallah
    Josseran, Loic
    Ouadahi, Mounir
    Grimaldi-Bensouda, Lamiae
    Dubourg, Olivier
    Annane, Djillali
    Mansencal, Nicolas
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 147 : 58 - 60
  • [38] Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
    Zhang, Peng
    Zhu, Lihua
    Cai, Jingjing
    Lei, Fang
    Qin, Juan-Juan
    Xie, Jing
    Liu, Ye-Mao
    Zhao, Yan-Ci
    Huang, Xuewei
    Lin, Lijin
    Xia, Meng
    Chen, Ming-Ming
    Cheng, Xu
    Zhang, Xiao
    Guo, Deliang
    Peng, Yuanyuan
    Ji, Yan-Xiao
    Chen, Jing
    She, Zhi-Gang
    Wang, Yibin
    Xu, Qingbo
    Tan, Renfu
    Wang, Haitao
    Lin, Jun
    Luo, Pengcheng
    Fu, Shouzhi
    Cai, Hongbin
    Ye, Ping
    Xiao, Bing
    Mao, Weiming
    Liu, Liming
    Yan, Youqin
    Liu, Mingyu
    Chen, Manhua
    Zhang, Xiao-Jing
    Wang, Xinghuan
    Touyz, Rhian M.
    Xia, Jiahong
    Zhang, Bing-Hong
    Huang, Xiaodong
    Yuan, Yufeng
    Rohit, Loomba
    Liu, Peter P.
    Li, Hongliang
    CIRCULATION RESEARCH, 2020, 126 (12) : 1671 - 1681
  • [39] Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?
    Verdecchia, Paolo
    Angeli, Fabio
    Mazzotta, Giovanni
    Ambrosio, Giuseppe
    Reboldi, Gianpaolo
    CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (06) : 742 - 746
  • [40] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Shrimpton, A. J.
    Walker, S. L. M.
    Ackland, G. L.
    BJA EDUCATION, 2020, 20 (11) : 362 - 367
12345